Intergen to offer "affordable" improved PCR technology
This article was originally published in Clinica
Executive Summary
US company Intergen is looking to license its Amplifluor universal DNA amplification and detection technology to diagnostics manufacturers. The company says that, unlike other fluorescence-based PCR systems, its product is affordable and easy to use in the lab.